Cargando…

Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice

Background: Gamma-aminobutyric acid (GABA) type A receptors are positively allosterically modulated by benzodiazepine binding, leading to a potentiated response to GABA. Diazepam (DZP, a benzodiazepine) is widely prescribed for anxiety, epileptic discharge, and insomnia, and is also used as a muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Tomonori, Nikaido, Yoshikazu, Shimoyama, Shuji, Masuyama, Nozomu, Notoya, Ayaka, Ueno, Shinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664496/
https://www.ncbi.nlm.nih.gov/pubmed/34899279
http://dx.doi.org/10.3389/fnagi.2021.777404
_version_ 1784613854839308288
author Furukawa, Tomonori
Nikaido, Yoshikazu
Shimoyama, Shuji
Masuyama, Nozomu
Notoya, Ayaka
Ueno, Shinya
author_facet Furukawa, Tomonori
Nikaido, Yoshikazu
Shimoyama, Shuji
Masuyama, Nozomu
Notoya, Ayaka
Ueno, Shinya
author_sort Furukawa, Tomonori
collection PubMed
description Background: Gamma-aminobutyric acid (GABA) type A receptors are positively allosterically modulated by benzodiazepine binding, leading to a potentiated response to GABA. Diazepam (DZP, a benzodiazepine) is widely prescribed for anxiety, epileptic discharge, and insomnia, and is also used as a muscle relaxant and anti-convulsant. However, some adverse effects – such as tolerance, dependence, withdrawal effects, and impairments in cognition and learning – are elicited by the long-term use of DZP. Clinical studies have reported that chronic DZP treatment increases the risk of dementia in older adults. Furthermore, several studies have reported that chronic DZP administration may affect neuronal activity in the hippocampus, dendritic spine structure, and cognitive performance. However, the effects of chronic DZP administration on cognitive function in aged mice is not yet completely understood. Methods: A behavioral test, immunohistochemical analysis of neurogenic and apoptotic markers, dendritic spine density analysis, and long-term potentiation (LTP) assay of the hippocampal CA1 and CA3 were performed in both young (8 weeks old) and middle-aged (12 months old) mice to investigate the effects of chronic DZP administration on cognitive function. The chronic intraperitoneal administration of DZP was performed by implanting an osmotic minipump. To assess spatial learning and memory ability, the Morris water maze test was performed. Dendritic spines were visualized using Lucifer yellow injection into the soma of hippocampal neurons, and spine density was analyzed. Moreover, the effects of exercise on DZP-induced changes in spine density and LTP in the hippocampus were assessed. Results: Learning performance was impaired by chronic DZP administration in middle-aged mice but not in young mice. LTP was attenuated by DZP administration in the CA1 of young mice and the CA3 of middle-aged mice. The spine density of hippocampal neurons was decreased by chronic DZP administration in the CA1 of both young and middle-aged mice as well as in the CA3 of middle-aged mice. Neither neurogenesis nor apoptosis in the hippocampus was affected by chronic DZP administration. Conclusion: The results of this study suggest that the effects of chronic DZP are different between young and middle-aged mice. The chronic DZP-induced memory retrieval performance impairment in middle-aged mice can likely be attributed to decreased LTP and dendritic spine density in hippocampal neurons in the CA3. Notably, prophylactic exercise suppressed the adverse effects of chronic DZP on LTP and spine maintenance in middle-aged mice.
format Online
Article
Text
id pubmed-8664496
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86644962021-12-11 Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice Furukawa, Tomonori Nikaido, Yoshikazu Shimoyama, Shuji Masuyama, Nozomu Notoya, Ayaka Ueno, Shinya Front Aging Neurosci Neuroscience Background: Gamma-aminobutyric acid (GABA) type A receptors are positively allosterically modulated by benzodiazepine binding, leading to a potentiated response to GABA. Diazepam (DZP, a benzodiazepine) is widely prescribed for anxiety, epileptic discharge, and insomnia, and is also used as a muscle relaxant and anti-convulsant. However, some adverse effects – such as tolerance, dependence, withdrawal effects, and impairments in cognition and learning – are elicited by the long-term use of DZP. Clinical studies have reported that chronic DZP treatment increases the risk of dementia in older adults. Furthermore, several studies have reported that chronic DZP administration may affect neuronal activity in the hippocampus, dendritic spine structure, and cognitive performance. However, the effects of chronic DZP administration on cognitive function in aged mice is not yet completely understood. Methods: A behavioral test, immunohistochemical analysis of neurogenic and apoptotic markers, dendritic spine density analysis, and long-term potentiation (LTP) assay of the hippocampal CA1 and CA3 were performed in both young (8 weeks old) and middle-aged (12 months old) mice to investigate the effects of chronic DZP administration on cognitive function. The chronic intraperitoneal administration of DZP was performed by implanting an osmotic minipump. To assess spatial learning and memory ability, the Morris water maze test was performed. Dendritic spines were visualized using Lucifer yellow injection into the soma of hippocampal neurons, and spine density was analyzed. Moreover, the effects of exercise on DZP-induced changes in spine density and LTP in the hippocampus were assessed. Results: Learning performance was impaired by chronic DZP administration in middle-aged mice but not in young mice. LTP was attenuated by DZP administration in the CA1 of young mice and the CA3 of middle-aged mice. The spine density of hippocampal neurons was decreased by chronic DZP administration in the CA1 of both young and middle-aged mice as well as in the CA3 of middle-aged mice. Neither neurogenesis nor apoptosis in the hippocampus was affected by chronic DZP administration. Conclusion: The results of this study suggest that the effects of chronic DZP are different between young and middle-aged mice. The chronic DZP-induced memory retrieval performance impairment in middle-aged mice can likely be attributed to decreased LTP and dendritic spine density in hippocampal neurons in the CA3. Notably, prophylactic exercise suppressed the adverse effects of chronic DZP on LTP and spine maintenance in middle-aged mice. Frontiers Media S.A. 2021-11-26 /pmc/articles/PMC8664496/ /pubmed/34899279 http://dx.doi.org/10.3389/fnagi.2021.777404 Text en Copyright © 2021 Furukawa, Nikaido, Shimoyama, Masuyama, Notoya and Ueno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Furukawa, Tomonori
Nikaido, Yoshikazu
Shimoyama, Shuji
Masuyama, Nozomu
Notoya, Ayaka
Ueno, Shinya
Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice
title Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice
title_full Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice
title_fullStr Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice
title_full_unstemmed Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice
title_short Impaired Cognitive Function and Hippocampal Changes Following Chronic Diazepam Treatment in Middle-Aged Mice
title_sort impaired cognitive function and hippocampal changes following chronic diazepam treatment in middle-aged mice
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664496/
https://www.ncbi.nlm.nih.gov/pubmed/34899279
http://dx.doi.org/10.3389/fnagi.2021.777404
work_keys_str_mv AT furukawatomonori impairedcognitivefunctionandhippocampalchangesfollowingchronicdiazepamtreatmentinmiddleagedmice
AT nikaidoyoshikazu impairedcognitivefunctionandhippocampalchangesfollowingchronicdiazepamtreatmentinmiddleagedmice
AT shimoyamashuji impairedcognitivefunctionandhippocampalchangesfollowingchronicdiazepamtreatmentinmiddleagedmice
AT masuyamanozomu impairedcognitivefunctionandhippocampalchangesfollowingchronicdiazepamtreatmentinmiddleagedmice
AT notoyaayaka impairedcognitivefunctionandhippocampalchangesfollowingchronicdiazepamtreatmentinmiddleagedmice
AT uenoshinya impairedcognitivefunctionandhippocampalchangesfollowingchronicdiazepamtreatmentinmiddleagedmice